Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| UNICANCER | 3 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| Institut Bergonié | 2 |
| Institut Cancerologie de l'Ouest | 2 |
| Novartis Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Celldex Therapeutics | 1 |
| Centre Jean Perrin | 1 |
| Centre Leon Berard | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 24 |
| Breast Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Neoplasm Metastasis | 3 |
| Pancreatic Neoplasms | 3 |
| Biliary Tract Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.